Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients
暂无分享,去创建一个
M. Borner | I. Zlobec | B. Schnüriger | D. Inderbitzin | V. Koelzer | A. Lugli | H. Dawson | M. Mallaev | M. Hädrich | Marion Hädrich
[1] A. Rogers,et al. Prognostic significance of tumor budding in rectal cancer biopsies before neoadjuvant therapy , 2014, Modern Pathology.
[2] L. Terracciano,et al. Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer. , 2013, Human pathology.
[3] I. Zlobec,et al. The impact of CpG island methylator phenotype and microsatellite instability on tumour budding in colorectal cancer , 2012, Histopathology.
[4] T. Hickish,et al. Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial , 2012, The Lancet. Oncology.
[5] R. Labianca,et al. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] Jacob G. Scott,et al. Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial , 2012 .
[7] M. Borner,et al. Role of Intra- and Peritumoral Budding in the Interdisciplinary Management of Rectal Cancer Patients , 2012, International journal of surgical oncology.
[8] M. Kurrer,et al. Intra-tumoral budding in preoperative biopsy specimens predicts lymph node and distant metastasis in patients with colorectal cancer , 2012, Modern Pathology.
[9] L. Terracciano,et al. Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients. , 2011, Human pathology.
[10] I. Zlobec,et al. Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget , 2010, Oncotarget.
[11] F. Bosman,et al. WHO Classification of Tumours of the Digestive System , 2010 .
[12] L. Terracciano,et al. CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a ‘pro-/anti-tumour’ approach to tumour host interaction in colorectal cancer , 2009, British Journal of Cancer.
[13] J. O’Sullivan,et al. Tumor Budding is a Strong and Reproducible Prognostic Marker in T3N0 Colorectal Cancer , 2009, The American journal of surgical pathology.
[14] M. Roh,et al. Tumor budding as a prognostic marker in stage-III rectal carcinoma , 2007, International Journal of Colorectal Disease.
[15] M. Mäkinen,et al. Budding invasive margin and prognosis in colorectal cancer--no direct association with beta-catenin expression. , 2006, European journal of cancer.
[16] H. Mitomi,et al. Evaluation of the usefulness of tumor budding on the prediction of metastasis to the lung and liver after curative excision of colorectal cancer. , 2005, Hepato-gastroenterology.
[17] M. Barten,et al. Tumour budding as prognostic factor in stage I/II colorectal carcinoma , 2005, Histopathology.
[18] M. Roh,et al. Intensity of Tumor Budding and Its Prognostic Implications in Invasive Colon Carcinoma , 2005, Diseases of the colon and rectum.
[19] H. Ueno,et al. A New Prognostic Staging System for Rectal Cancer , 2004, Annals of surgery.
[20] Tetsuro Nakamura,et al. Budding Is Useful to Select High-Risk Patients in Stage II Well-Differentiated or Moderately Differentiated Colon Adenocarcinoma , 2003, Diseases of the colon and rectum.
[21] K. Hase,et al. Tumor Budding at the Invasive Margin Can Predict Patients at High Risk of Recurrence After Curative Surgery for Stage II, T3 Colon Cancer , 2003, Diseases of the colon and rectum.
[22] B. Leggett,et al. APC mutation and tumour budding in colorectal cancer , 2003, Journal of clinical pathology.
[23] M. Oya,et al. Budding as a Risk Factor for Lymph Node Metastasis in pT1 or pT2 Well-Differentiated Colorectal Adenocarcinoma , 2002, Diseases of the colon and rectum.
[24] H. Ueno,et al. Tumour `budding' as an index to estimate the potential of aggressiveness in rectal cancer , 2002, Histopathology.
[25] K. Hase,et al. Prognostic value of tumor “budding” in patients with colorectal cancer , 1993, Diseases of the colon and rectum.
[26] M. Morimatsu,et al. An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer , 1989, Cancer.